YIDU TECH Subsidiary Secures Contract for Dr. Buddy Implementation and Maintenance

Stock News05-06 06:20

YIDU TECH (02158) announced that its subsidiary, EVYD Research Private Limited, has successfully won a bid from Singapore Health Services Pte Ltd for the implementation, support, and maintenance of the Dr. Buddy project. The total contract value is approximately SGD 2.278 million. This project represents a significant milestone in the group's expansion into the Singapore market. YIDU TECH is a core driver of intelligent upgrades within China's healthcare system. The group deeply empowers the entire industry chain—encompassing healthcare, pharmaceuticals, insurance, and patients—with smart decision-making solutions, aiming to make precision medicine accessible to everyone. By simulating physicians' clinical decision-making logic, training on actual disease progression data, and repeatedly validating outcomes in real-world settings, the group has developed an AI that truly understands diseases. This provides measurable value to key segments of the healthcare ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the path from molecule to patient, enabling patients to access more affordable precision diagnostics and treatments, and providing public health systems with more scientific support. Through its proprietary system-level intelligence, YIDU TECH is creating a more resilient, compassionate, efficient, and universally accessible future for healthcare.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1196654532?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-06 06:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196654532","market":"nz","top_or_hot":-1,"title":"YIDU TECH Subsidiary Secures Contract for Dr. Buddy Implementation and Maintenance","media":"Stock News","content":"<p>YIDU TECH (02158) announced that its subsidiary, EVYD Research Private Limited, has successfully won a bid from Singapore Health Services Pte Ltd for the implementation, support, and maintenance of the Dr. Buddy project. The total contract value is approximately SGD 2.278 million. This project represents a significant milestone in the group's expansion into the Singapore market. YIDU TECH is a core driver of intelligent upgrades within China's healthcare system. The group deeply empowers the entire industry chain—encompassing healthcare, pharmaceuticals, insurance, and patients—with smart decision-making solutions, aiming to make precision medicine accessible to everyone. By simulating physicians' clinical decision-making logic, training on actual disease progression data, and repeatedly validating outcomes in real-world settings, the group has developed an AI that truly understands diseases. This provides measurable value to key segments of the healthcare ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the path from molecule to patient, enabling patients to access more affordable precision diagnostics and treatments, and providing public health systems with more scientific support. Through its proprietary system-level intelligence, YIDU TECH is creating a more resilient, compassionate, efficient, and universally accessible future for healthcare.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YIDU TECH Subsidiary Secures Contract for Dr. Buddy Implementation and Maintenance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYIDU TECH Subsidiary Secures Contract for Dr. Buddy Implementation and Maintenance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-06 06:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YIDU TECH (02158) announced that its subsidiary, EVYD Research Private Limited, has successfully won a bid from Singapore Health Services Pte Ltd for the implementation, support, and maintenance of the Dr. Buddy project. The total contract value is approximately SGD 2.278 million. This project represents a significant milestone in the group's expansion into the Singapore market. YIDU TECH is a core driver of intelligent upgrades within China's healthcare system. The group deeply empowers the entire industry chain—encompassing healthcare, pharmaceuticals, insurance, and patients—with smart decision-making solutions, aiming to make precision medicine accessible to everyone. By simulating physicians' clinical decision-making logic, training on actual disease progression data, and repeatedly validating outcomes in real-world settings, the group has developed an AI that truly understands diseases. This provides measurable value to key segments of the healthcare ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the path from molecule to patient, enabling patients to access more affordable precision diagnostics and treatments, and providing public health systems with more scientific support. Through its proprietary system-level intelligence, YIDU TECH is creating a more resilient, compassionate, efficient, and universally accessible future for healthcare.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1617","symbol_name":"AI医疗","start_time":0,"source_url":"","article_id":"1196654532","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196654532","pubTimestamp":1778019618,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"YIDU TECH (02158) announced that its subsidiary, EVYD Research Private Limited, has successfully won a bid from Singapore Health Services Pte Ltd for the implementation, support, and maintenance of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1617":"AI医疗","BK1189":"医疗保健技术","02158":"医渡科技","BK1518":"SaaS概念"},"translate_title":"医渡科技子公司获得Dr.Buddy实施和维护合同","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02158":1},"content_text":"YIDU TECH (02158) announced that its subsidiary, EVYD Research Private Limited, has successfully won a bid from Singapore Health Services Pte Ltd for the implementation, support, and maintenance of the Dr. Buddy project. The total contract value is approximately SGD 2.278 million. This project represents a significant milestone in the group's expansion into the Singapore market. YIDU TECH is a core driver of intelligent upgrades within China's healthcare system. The group deeply empowers the entire industry chain—encompassing healthcare, pharmaceuticals, insurance, and patients—with smart decision-making solutions, aiming to make precision medicine accessible to everyone. By simulating physicians' clinical decision-making logic, training on actual disease progression data, and repeatedly validating outcomes in real-world settings, the group has developed an AI that truly understands diseases. This provides measurable value to key segments of the healthcare ecosystem: equipping doctors with more precise and efficient decision-making tools, helping pharmaceutical companies shorten the path from molecule to patient, enabling patients to access more affordable precision diagnostics and treatments, and providing public health systems with more scientific support. Through its proprietary system-level intelligence, YIDU TECH is creating a more resilient, compassionate, efficient, and universally accessible future for healthcare.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1196654532","isCrawlerRequest":true}